Calcium phosphates (CaP) are important biomaterials used in tissue engineering and drug delivery, due to their biocompatibility, low toxicity, and osteoconductivity. However, controlling the phase of CaP, especially tricalcium phosphate (TCP), is very challenging under mild conditions, particularly when using one preparation protocol for all CaP phases. It is also crucial to produce these biomaterials economically and reproducibly. Herein, three of the most commonly employed CaP, including beta-tricalcium phosphate (β-TCP), dicalcium phosphate anhydrous (DCPA), and hydroxyapatite (HA) were, for the first time, successfully synthesised by altering the reaction solvent, using calcium acetate monohydrate as a precursor and a rapid microwave-assisted synthetic method. A variety of CaP particle morphologies were obtained, including elliptical and plate-shaped with different porosities. Compared with conventional heating, CaP biomaterials synthesised using microwave heating showed greater reproducibility, higher yields, and shorter reaction time. By varying the reaction solvents, morphologies and phases of CaP were controlled, leading to an enhanced protein bovine serum albumin (BSA) loading, with a higher BSA absorption observed according to the trend DCPA> β-TCP > HA. Furthermore, the phase, specific surface area and pores size were shown to play decisive roles in protein desorption with a higher release amount observed according to the trend DCPA > β-TCP
INTRODUCTION
Calcium phosphates (CaP) are a group of inorganic compounds present in mammalian bone and teeth. They have gained increasing interest in bone regeneration and drug delivery, owing to their low toxicity, excellent biocompatibility, nonimmunogenicity and osteoconductive properties. 1, 2, 3, 4, 5 CaP materials are used in a wide range of biomedical products such as coatings on orthopaedic and dental implants, prosthetic coatings and composites, as well as scaffolds for bone regrowth, depending on their resorbability and bioactivity. 6, 7 For instance, the least soluble CaP phase, hydroxyapatite (HA), is widely applied as a coating in orthopaedic and dental implants, and in liquid chromatography of biological compounds due to chemical similarities to the minerals in bone and teeth. On the other hand, other CaP phases such as beta-tricalcium phosphate (β-TCP) and dicalcium phosphate anhydrous (DCPA), which exhibits a higher aqueous solubility and hence resorption rate compared with HA, can also act as a degradable drug carrier and scaffold material. 2, 8 Finally, the most important advantage of CaP biomaterials is that their degradation in the human body does not create any toxic substances compared to some polymers (e.g. polycaprolactone). 9 Formation of CaP phases relies on the presence of components from orthophosphoric acid (H 3 2 ], possessing Ca/P ratios ranging from 1 to 1.67, are amongst the most useful calcium phosphate phases in the biomedical field. Acidity and solubility of these CaP materials are inversely related to the Ca/P ratio. Hence, the relative solubility of these phases is as follows; DCPA > β-TCP > HA. 11, 12 CaP compounds can be categorized into (i) low-temperature CaP and (ii) hightemperature CaP, where the former can be formed in an aqueous solution at low temperature and is a potential precursor for the high-temperature phases (e.g. β-TCP and HA). 12 On the other hand, synthesis of β-TCP typically requires reaction temperatures above 700-800 ˚C. 5 Generally, it is a two-step reaction, firstly either the calcium deficient hydroxyapatite (CDHA) or an intermediate phase (amorphous calcium phosphate) is obtained before transforming into β-TCP when increasing in the reaction time. 13, 14 Several low-temperature methods have been studied to synthesise the high-temperature CaP phases, including both β-TCP and HA, but at the cost of exponentially increasing the reaction time (e.g. more than 8 hours to crystallise β-TCP particles) and subsequent control of particle shape is generally poor. 14 Hence, the synthesis of different CaP phases with a high yields under mild reaction conditions still remains a challenge.
By using microwave-assisted synthesis, various CaP phases can be targeted using an identical preparation pathway as developed in this study. Microwave heating is based on dielectric heating where the heat is generated internally due to the rotation, friction and collisions of molecules as the permanent dipole moment of solvent molecules attempts to align with the applied electromagnetic field. It can allow the low temperature and fast production of crystalline particles with controlled morphology, high yields and heating rates, better selectivity and improved reproducibility. 15, 16, 17, 18 The heating rate and efficiency of microwave heating depends on the nature of the coupling of the reaction mixture with the microwave field (tan δ). Therefore in this study, strong microwave absorbing solvents, (i.e. methanol, ethanol and water) were used to allow fast and homogeneous heating during the reaction. Various CaP, from low temperature to high temperature phases (e.g. β-TCP, DCPA and HA), were successfully fabricated without any additional surfactants. As a result, no additional steps were required to remove the surfactants, simplifying the synthesis process and lowering the cost. Interestingly, calcium acetate monohydrate was found to be a suitable precursor for the synthesis of different phases of calcium phosphates under identical mild experimental conditions, which could not be achieved by other precursors (for example, calcium nitrate tetrahydrate and calcium hydroxide). 19 CaP materials are widely used as drug carriers and non-viral gene carriers. Systematic delivery of drugs in the human body suffers from problems associated with enzymatic degradation and adverse effects when traveling in human blood. 20 Conversely, localised delivery of therapeutics using CaP nanovectors can offer reduced toxicity and improved efficacy. For instance, a combination of CaP bioceramics and proteins, e.g. bone morphogenetic proteins or fibronectin, can notably improve the osteogenic potential of bone substitutes and reduce the recovery period by enhancing the osteoblastic differentiation. 21 Nano-sized CaP particles are highly interesting drug delivery agents, as their higher specific surface areas provide increased carrier sites. Furthermore, nanocarriers can significantly overcome the limitations of direct delivery by reducing the possibility of enzymatic degradation and possible hazardous side effects. 20 In addition, nano-sized CaP particles more closely mimic the natural bone nanostructure and induce bone regrowth more effectively. 22 Hence, increasing efforts have been made to control the particle size, porosity, shape, surface structure and internal structure of CaP nanomaterials to improve drug carrier properties. However, control over the loading capacity and release properties still remain an important challenge in the biomedical area. 2 The efficacy of these carriers for drug delivery is strongly dependent on the ability to bind the drug effectively, which is dominated by electrostatic forces between the drug molecules and the material surface. 7 In addition, controlling material morphology and porosity can provide the desired surface area for optimum adsorption of drug molecules. 23 Thus, by tuning the phase and morphology of CaP, control of protein loading and release rate should be possible. Therefore this study focuses on the control of phase, morphology and porosity of CaP by a facile route, in an attempt to manipulate the drug adsorption and release properties of these highly biocompatible materials. 
EXPERIMENTAL SECTION

Synthesis
RESULTS AND DISCUSSION
Analysis of Calcium Phosphates
A rapid and homogeneous microwave heating method was chosen in this study to enhance the selectivity of CaP phases and control particle morphology. This unique chemical method produced high yields of three important CaP phases, including β-TCP, DCPA and HA, by altering the solvent and using calcium acetate monohydrate as a precursor (calcium nitrate tetrahydrate and calcium hydroxide did not yield β-TCP under similar experimental condition, XRD pattern not shown herein). The chemical reactions occurring in this study are based on the acid-base reaction, (i.e. acidic phosphoric acid with basic calcium acetate), but β-TCP is the neutral phase, whilst DCPA and HA are slightly acidic and basic, respectively. 24 Initially, CaP biomaterials were synthesised via microwave irradiation at 200 ˚C, using a 5 minute reaction time. As depicted in Figure 1 , a different CaP phases were obtained using different solvents while keeping the same precursor Ca/P molar ratio constant and without adjustment in pH. All The synthesised CaP particles appear to have a preferred growth orientation according to the solvent used, resulting in a variation in morphology, observed by TEM (Figure 2) . After a reaction time of five minutes, DCPA particles were found to be elliptical with a dimension of 50-110 nm x 40-90 nm, HA materials were plate-like in shape (1-5 µm x 0.4-1.2 µm), while β-TCP were needle-shaped nanoparticles with a 20-80 nm x 10-20 nm. Short reaction times resulted in low yields, for example, less than 10 % β-TCP was produced when the reaction time was 5 minutes. However, when the microwave reaction time further increased to one hour, no change in calcium phosphate phase was found (as verified through XRD, see Supporting Information, S1), but the longer reaction time increased the yield and also changed the morphology (Figure 3 and Supporting Information, S2). The high yield of all three phases of CaP indicates that the temperature was high enough to provide sufficient energy not only to drive the reaction, but also to drive it to completion. The The mesoporosity of β-TCP, DCPA and HA particles (prepared at 200 ˚C with one hour holding time) was further analysed by nitrogen adsorption/desorption analysis. DCPA shows a type IV isotherm indicative of a mesoporous material, with a relatively narrow distribution of pore diameters as shown by the sharp peak in the range of 4-12 nm in the BJH plot (Figure 4) . β-TCP nanoparticles exhibit a similar type IV isotherm but a larger pore size of 10-40 nm. Only HA particles obtained in this study show a type II isotherm with zero pore volume, indicating that they are nonporous. Regarding the specific surface area, DCPA particles have the largest specific surface area (77.8 m 2 /g), followed by TCP (34.4 m 2 /g) and then HA particles (16.1 m 2 /g) (see Table 1 ), consistent with their pore volume. 
Phase Selection of Calcium Phosphates
Chemical reactions in microwave synthesis are highly dependent on the nature of reaction ) after addition of the phosphoric acid into the calcium precursor solution and acted as the precursor to HA (Equation 3b). 7 Indeed, water is always needed in the chemical transformation of brushite, therefore, it is hydraulic compared to other phases. 24 For DCPA, no initial phase was formed when mixing the two precursors at room temperature (as found by XRD-not reported herein) as calcium acetate is totally insoluble in ethanol at room temperature. However, after microwave assisted heating, slow dissolution and calcium ion release allowed the formation of
DCPA (Equation 2).
Microwave heating in a closed vessel system produces a high vapour pressure that can further facilitate CaP nucleation and growth. For example, methanol is a highly volatile organic solvent. Hence, it produced the highest vapour pressure, 400-550 psi, followed by ethanol with approximately 300-400 psi and water at 110-200 psi (measured by a pressure probe located in the cavity of the microwave reaction system -see Supporting Information, S6). However, the vapour pressure of the solvents does not play a decisive role in the final product phase formed but may contribute in combination with microwave heating to accelerate the reaction rate, as β-TCP, DCPA and HA can be synthesised at room temperature in similar solvents but with an extended reaction time. 14, 29, 30 For instance, synthesis of both β-TCP and DCPA require five minutes microwave irradiation instead of approximately eight and three hours, respectively at room temperature. 14, 30 Furthermore, reducing the reaction temperature of microwave assisted synthesis to ca. 70 ˚C did not produce any β-TCP in five minutes. Therefore, the rapid synthesis and phase selectivity of CaP biomaterials is the product of both a highly pressurized system and rapid heating associated with our microwave assisted synthesis. Water is a highly polar solvent, so the degree of dissociation of both precursors is relatively higher. For example, calcium acetate monohydrate dissolves in water, but only partially dissolves in alcohols at room temperature. 34 Consequently, the higher solubility of precursors in water leads to the insoluble HA phase produced in water. Furthermore, the pK a value in water (pK a =2.11) indicates a higher dissociation of phosphoric acid than in alcohol (pK a = 5.15-6.15), which shifts the reaction from left to right (Equation 4) and more H 4 2− ions favour brushite and then HA formation in water. 35 
In addition, Ca/P ratio of these phases and the solubility of precursors are intimately related.
Indeed, the use of alcohols tends to reduce the Ca/P ratio of the final CaP phase. 36 Based on Table 1 , HA, with the highest Ca/P ratio, was prepared in water because the degree of dissociation of both precursors in water are relatively higher than both in alcohols, and OHions were present in water. Calcium acetate monohydrate is slightly soluble in methanol and almost insoluble in ethanol, hence, the Ca 2+ ion concentration in ethanol at room temperature would be lower than in methanol. Amorphous calcium phosphate, with Ca/P molar ratio of 1.2-2.2, was obtained when mixing the two precursors in methanol after a few hours at room temperature. 14, 37 Therefore, β-TCP preferably forms in methanol due to slightly higher concentration of calcium ions than in ethanol in which DCPA with a low Ca/P ratio of 1.00 was produced.
Morphology Control of Calcium Phosphates
The morphology of CaP produced was strongly influenced by the type of reaction solvent. Solute-solvent interaction can change the crystal growth kinetics and surface energy, thus enhancing or inhibiting growth at certain crystal faces. 38, 39 Reardon et al. reported that the morphology evolution of CaP materials relied on the concentration of the residue precursors in the solution after the formation of nuclei; a higher precursor concentration favours onedimensional growth and a lower precursor concentration allowed three-dimensional growth of nanocrystals. 17 A measure of the efficiency of a solvent to convert the absorbed microwave energy to thermal energy is known as the dissipation factor tan δ, as listed in Table 2 ; higher tan δ values indicates greater heat dissipation to the solvent molecules, allowing a more rapid achievement of the desired temperature. 33 Therefore, a faster heating and higher vapour pressure produce an environment in which nucleation is faster, in the order methanol > ethanol > water.
Larger amounts of nuclei which form decreases the precursor ion concentration or the chemical potential in alcoholic solvents, thus favouring three-dimensional growth of crystals and leading to small needle-shaped β-TCP and elliptical DCPA particles in methanol and ethanol, respectively. Inversely, a high precursor ion concentration in water resulted on a preference for one-dimensional growth. 17 Furthermore, the reaction time also affected the size and morphology of the crystals; larger crystals were obtained with longer reaction times. As the reaction time was extended, the needle-shaped β-TCP particles transformed into regular elliptical shapes in methanol, DCPA agglomerated into larger plate shapes in ethanol (some smaller particles still can be seen in Supporting Information, S2). HA retained its morphology but increased in size.
Protein Loading and Release
The loading efficiency of therapeutic agents and general bioactivity were studied using bovine serum albumin (BSA) as a model protein.
BSA loading was carried out for 24 hours to ascertain the drug delivery performance of the CaP biomaterials. The specific surface area and pore size of CaP materials influenced the protein adsorption capacity. Table 1 displays the amount of BSA adsorbed onto the three CaP materials. DCPA particles have the largest specific surface area (77.8 m 2 /g), followed by β-TCP (34.4 m 2 /g) and then HA particles (16.1 m 2 /g) as shown in Table 1 , consistent with their pore volume. The micron plate-shaped HA particles prepared in water as a solvent showed a 15 wt% BSA loading due to its comparatively small surface area of 16.1 m 2 /g. A threefold increase in loading efficiency for DCPA particles compared to HA particles was found, which correlates with the 380 % increase in surface area and higher meso-porosity observed. β-TCP particles represent a 41 wt% loading of BSA, only 18 wt% less than DCPA although its surface area is 2 times smaller than DCPA.
The adsorption of BSA molecules onto CaP particle surfaces is mainly driven by the electrostatic interaction between the charged amino acids in the BSA molecule and the CaP particle surface where the highly ionic CaP surface exerts greater electrostatic forces to interact with the functional groups in BSA molecules. 20, 40, 41 Specifically, this interaction occurs between Ca 2+ in the CaP and COOin BSA molecules. A higher surface area increases the overall charge per unit weight (more Ca 2+ ions on the surfaces) which results in a higher degree of electrostatic interaction between CaP and BSA. 20 Therefore, the smallest surface area HA with fewest Ca 2+ adsorption sites on the surface adsorbed the least amount of BSA molecules. Zhu et al. reported that greater amounts of protein adsorbed onto porous surfaces, concluding that the higher porosity produced more binding sites, 21 and is in agreement with our results-highly porous DCPA adsorbs the highest amount of BSA. It was also reported that the pore size also affects the BSA adsorption capacity; large mesopores allow more large biomolecules such as BSA (ellipsoid with dimensions 14 nm x 3.8 nm x 3.8 nm) to be adsorbed. 23, 42, 43 The β-TCP material has less than half the surface area of the DCPA sample, but demonstrated ca. 82% of the BSA loading amount achieved by DCPA. This strongly indicates that the mesoporous structure of β-TCP (15-40 nm) can host more BSA molecules in comparison to the smaller pores (4-12 nm) in DCPA. Conversely, HA has the smallest surface area and a nonporous structure, resulting in the smallest loading amount of BSA. This characteristic suggests that drug loading may be controlled by not only surface area but also pore size. The other important aspect of a drug delivery medium is its release profile. The BSAloaded CaP samples were incubated in vitro to examine this property. All the materials exhibit a two-stage release profile (Figure 5 (a) and (b) ) consisting of an initial fast release stage (0-10 h), followed by a slow linear release stage (10-96 h). Based on Figure 5 (a), the BSA released (wt%) over the whole delivery period was the largest for HA, in comparison, DCPA exhibited the smallest release (wt%), regardless of loading amount. It was found that 62 wt% of BSA (4.7 mg) was released from HA, 40 wt% (8.2 mg) from β-TCP and only 31 wt% (7.8 mg) of BSA from DCPA particles after the first 10 hours ( Figure 5(b) ). According to Figure 5 with the first stage. It is estimated 100% of the protein would be released after 7 and 9 days from the β-TCP and DCPA particles respectively; in contrast to just 6 days for HA, which could be due to its lower adsorption capacity. During the second release phase (10-96 h), DCPA shows the largest release amount of BSA (15.4 mg), compared to 15.2 mg for β-TCP and only 6.7 mg for HA. The total amount of BSA released from DCPA is expected to surpass β-TCP after 96 hours ( Figure 5(b) ).
The two-stage release mechanism for all CaP phases is determined by the physical states of the adsorbed molecules and dissolution rate of CaP material. 20, 21, 44 The fast initial release is attributed to loosely bonded BSA molecules (physical adsorbed molecules) present on the outer adsorption layers where the electrostatic forces are weak and dominated by surface area. The increase in the thickness of BSA layers on the CaP surfaces results in the molecules not being tightly bound. The second release stage is dominated by the dissolution rate of CaP; higher solubility of CaP has a higher dissolution rate, enabling a higher amount of the BSA to be released ( Figure 5(b) ). 20 Thus, the protein release amount is directly linked to CaP solubility:
DCPA > β-TCP > HA. However, another important influence of protein release rate is the pore size in which the BSA molecules are captured. Gao et al. reported that the drug molecules easily leaked out or released from the larger pore surfaces. 43 Therefore, the larger pores of β-TCP can also explain the higher release amount of BSA compared to DCPA over the same release period.
Therefore, it can be concluded that the release profile is affected by a trifecta of surface area, CaP dissolution rate and pore size.
CONCLUSIONS
In summary, morphology controlled CaP materials (β-TCP, DCPA and HA) have been successfully synthesized in high yield (>80%) using rapid microwave-assisted synthesis under mild processing conditions and short reaction times without addition of any surfactants.
Furthermore, calcium acetate monohydrate was found to be the only suitable precursor to prepare different phases of CaP. The CaP phases formed were shown to be controlled by the type of solvents used rather than the Ca/P molar ratio, as well as residence time and reaction temperature/vapor pressure of solvents. This was attributed to the solubility of the precursors and polarity index of solvents. The efficacy of CaP biomaterials as drug carriers is strongly linked to their specific surface area and pore size. Increasing the specific surface area provides more binding sites; DCPA particles represented the highest loading amount of BSA (50 wt%) in our study. The elliptical β-TCP nanoparticles exhibited a 41 wt% BSA loading, a 2.7 times enhancement in BSA loading capacity compared with the lowest surface area plate-shaped HA materials.
Interestingly, mesopores were formed in β-TCP and DCPA during preparation in alcohol solvents (methanol and ethanol) and resulted in higher BSA loading, demonstrating that the pore size also affects the loading capacity, with the larger pore size (similar to the size of BSA) of β-TCP increasing the adsorption of BSA macromolecules (cage effect).
Furthermore, the release of BSA from different CaP were characterised by a two-stage profile and were controlled by the surface area, dissolution rate of CaP and pore size. A higher dissolution rate of CaP facilitated a larger BSA release amount. Importantly, the larger pores in the β-TCP material may also influence the higher release amount of BSA compared to DCPA (smaller pore size) over the same release period. In short, the phase and morphology-controlled
